AMERSHAM, England-- (BUSINESS WIRE)--GE Healthcare’s Medical Diagnostics division announced the market reintroduction of Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results